Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

RVNCRVNC
Showing 3 of 25 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in REVANCE THERAPEUTICS INC

MetLife Investment Management, LLC previously held 0 shares of RVNC (REVANCE THERAPEUTICS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$292,088

Total Shares Change

-56,279

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q4
Increased
60,514
+7.5%
$183,9630.0%
24
2024-Q3
Increased
56,279
+1.8%
$292,0880.0%
24

Other major holders of RVNC: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used